The first stage of the rollout of the vaccines in opposition to the coronavirus started on Tuesday with Serum Institute of India – the producer of Oxford College’s Covishield – transport out its first lot of vials. The Union Well being Ministry, in a press convention right this moment, stated the inoculation programme, billed because the world’s largest, is on observe. It defined the vaccination drive in numbers.
In line with the Well being Ministry, 110 lakh doses of Covishield are being procured at Rs 200 per dose (excluding taxes). 55 lakh doses of Covaxin — developed by Hyderabad-based Bharat Biotech — are additionally being procured. Each these vaccines have been authorized by the nation’s drug regulator for restricted emergency use.
Bharat Biotech is charging Rs 295 per dose for 38.5 lakh doses. The firm, which has partnered with the Indian Council of Medical Analysis for the vaccine, will give 16.5 lakh doses to the centre freed from price.
The centre has acquired 54,72,000 doses of vaccines in opposition to the coronavirus to this point, the Union Well being Ministry stated right this moment. “100% doses to be acquired by January 14 in all states/UTs,” it added.
On why solely 110 lakh doses had been ordered from the Serum Institute when the nation wanted far more, the ministry stated, “We are going to stagger our provide orders.”
The ministry stated that the vaccines developed or manufactured in India are method cheaper than their western counterparts. “Pfizer’s two doses will price round Rs 2,800; Moderna’s two doses could price round Rs 5,400,” it stated.
4 different vaccines being developed or manufactured in India could also be accessible for emergency use within the subsequent few months, it added.
For the vaccination that begins from January 16, 2360 grasp trainers, 61,000 programme managers, 2 lakh vaccinators, 3.7 lakh different personnel have been educated to this point, it stated.